Vanessa's Comment:

 The SonoCloud-9 is an investigational implantable device used to open the blood-brain barrier in order to improve delivery of anticancer treatments to the brain. Results from the Phase 1 SonoCloud-9 study can be read here. A Phase 2a study just opened at Northwestern University in Chicago for newly diagnosed GBM patients with unmethylated MGMT gene promoter. 

---

Posted on: 04/22/2024

Carthera partners with Agenus and Northwestern University for phase 2a trial combining SonoCloud-9 with checkpoint inhibitors to treat glioblastoma

 

---

Click HERE to return to brain tumor news headlines.